Follow the CellaVision AB stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, CellaVision AB has logged 12 reports. Market capitalisation: €4bn. The latest transaction was disclosed on 3 September 2026 (Purchase). Among the most active insiders: christer Fåhraeus. Every trade is free.
12
Insider Decl.
n/a
Thresholds
€2m
11 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
Buys €2mn/a Sells
Fundamental score
Ranked 6,144 of 29,063 companies
66.1
score / 100
Value
48
Quality
85
FCF yld2.9%
Earn yld3.9%
EV/EBITDA17.0x
ROE15%
Gross mgn68%
Net mgn20%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
20,000 shares@ €11.35920.068% mcap50.0% of flowAktieISINISIN SE0000683484FI:A003X894-1
12 of 12 declarations
Acerca de CellaVision AB
CellaVision AB es una empresa enfocada en el desarrollo de soluciones de análisis de imágenes para diagnósticos médicos. Cotiza en la Bolsa de Estocolmo (XSTO).